stockrow
Friday 6 November 2026
Export IRON’s income statement to Excel — free account
Disc Medicine, Inc.
IRON Healthcare Biotechnology
- EPS
- +2.53%
- Free cash flow
- +7.83%
- Total debt
- +106.5%
Quarter to June 2026, against a year earlier
78.51
0.04
+0.05%
Follow IRON
Alert me
Disc Medicine, Inc. (IRON) Net income
Disc Medicine, Inc.'s net income for fiscal 2025 was −$212.2M, compared with −$109.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$245.9M. Over the past ten years it has ranged from −$212.2M (fiscal 2025) to $0.00 (fiscal 2019) — the current reading is the lowest in ten years. Net income has fallen for 4 consecutive fiscal years. Disc Medicine, Inc. ranks 542nd of 605 Biotechnology companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$212.2M | — |
| FY2024 | −$109.4M | — |
| FY2023 | −$76.4M | — |
| FY2022 | −$46.8M | — |
| FY2021 | −$36.0M | — |
| FY2020 | −$40.8M | — |
| FY2019 | $0.00 | — |
| FY2017 | $0.00 | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | −$59.5M | — |
| Mar 2026 | −$63.5M | — |
| Dec 2025 | −$60.5M | — |
| Sep 2025 | −$62.3M | — |
| 22 more quarters | Free account |
Against its own ten years
Low −$212.2M
High $0.00
Ten-year median
−$43.8M
Current reading's percentile
13
Net income against peers
| Company | Net income |
|---|---|
| ACAD ACADIA Pharmaceuticals Inc. compare | $362.2M |
| TNGX Tango Therapeutics, Inc. compare | −$123.7M |
| PBLS Parabilis Medicines, Inc. compare | −$170.9M |
| IOVA Iovance Biotherapeutics, Inc. compare | −$220.5M |
| IRON Disc Medicine, Inc. | −$245.9M |
| RLAY Relay Therapeutics, Inc. compare | −$286.0M |
| XENE Xenon Pharmaceuticals Inc. compare | −$409.2M |
| DYN Dyne Therapeutics, Inc. compare | −$519.4M |
| VKTX Viking Therapeutics, Inc. compare | −$627.2M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item